Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01141959 · ClinicalTrials.gov registry record
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT01141959: Completed study, sponsored by Fred Hutchinson Cancer Center.
NCT01141959 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01141959 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The investigators are interested in identifying patient-specific factors related to donor chimerism in patients who receive nonmyeloablative hematopoietic stem cell transplants from haploidentical donors. We will look how patients' bodies break down and immediately respond to cyclophosphamide, fludarabine and mycophenolate mofetil.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-12 |
What the finished NCT01141959 record still lists
NCT01141959 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01141959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01141959 about?
NCT01141959 is a clinical study titled "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients". The investigators are interested in identifying patient-specific factors related to donor chimerism in patients who receive nonmyeloablative hematopoietic stem cell transplants from haploidentical donors. We will look how patients' bodies break down and immediately respond to cyclophosphamide, fluda...
What is the current status of trial NCT01141959?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2010-05. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01141959?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia